Written by International Journal of Pharmacology and Clinical Sciences, 2024, 13, 2, 42.
Published: November 2024
Type: Drug Review
Authors: Juman Alsaab
Author(s) affiliations:
Juman Alsaab, Pharm D
Ministry of Health, Riyadh, SAUDI ARABIA.
Abstract
Regulations: had been registered in the United States of America (Ryzneuta).
Registration number (S.A.): Not available.
Insurance Drug Formulary (S.A.): Not available.
General Information:
Registered Company: Evive Biotech.
Regulatory Status: R.X.
Mechanism of Action: colony-stimulating factor that works on hematopoietic cells by binding to specific cell surface receptors, then stimulating proliferation, commitment, differentiation, and end-cell functional activation Read more…
Registration number (S.A.): Not available.
Insurance Drug Formulary (S.A.): Not available.
General Information:
Registered Company: Evive Biotech.
Regulatory Status: R.X.
Mechanism of Action: colony-stimulating factor that works on hematopoietic cells by binding to specific cell surface receptors, then stimulating proliferation, commitment, differentiation, and end-cell functional activation Read more…